2014年国际泌尿病理学会分级系统对根治性前列腺切除术后前列腺癌患者的长期随访预测价值
研究纳入单中心1991—1999年635例根治性前列腺切除术病例,按2014年ISUP分级重新评级并长期随访(中位15.25年)。结果显示2014年ISUP分级系统是生化复发和临床复发的独立预测因素,预测效能优于2005年ISUP改良Gleason系统;将三级模式/分级纳入ISUP评分未显著改善其效能。
要点
- 中位随访15年,276例(44%)出现生化复发,41例(7%)出现临床复发。
- 与1992年Gleason系统相比,337例(53%)升级,70例(11%)降级。
- 2014年ISUP分级系统对生化复发和临床复发的预测效能显著优于2005年ISUP改良Gleason系统。
核心结论
- 2014年ISUP分级系统是生化复发和临床复发的显著独立预测因素,效能优于2005年ISUP改良Gleason系统。
- 该分类系统具有影响根治性前列腺切除术后临床决策的潜力。
研究设计与样本
- 从单中心数据库识别1991—1999年635例根治性前列腺切除术病例。
- 进行组织病理学复核,按2014年ISUP分级系统重新评级,并获取所有相关临床病理数据和临床随访(中位15.25年,范围0.3—26年)。
- 采用对数秩检验、Kaplan-Meier法、Cox回归和Harrell一致性c指数分析。
主要发现
- 中位随访15年,276例(44%)出现生化复发,41例(7%)出现临床复发。
- Grade Group 1、2、3、4、5级分别见于112例(18%)、307例(48%)、129例(20%)、33例(5%)和54例(9%)。
- 与1992年Gleason系统相比,337例(53%)升级,70例(11%)降级。
- Grade Group(HR 4.9;P < 0.001)和术前前列腺特异性抗原(PSA)水平(HR 1.4;P < 0.001)是生化复发的独立预测因素。
- 仅Grade Group 5(HR 12.3;P = 0.02)、术前PSA(HR 1.6;P < 0.001)、pT3b期(HR 3.1;P = 0.03)和pT4期(HR 12.4;P < 0.001)独立预测临床复发。
关键数值与推荐
- Harrell一致性c指数显示,与2005年ISUP改良Gleason系统相比,2014年ISUP分级系统对生化复发、临床复发以及前列腺癌特异性死亡的预测显著更优。
- 以三级模式替代次要模式未改变2014年ISUP分级系统的预后效能。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess the relationship between the International Society of Urological Pathology (ISUP) 2014 grading system, biochemical recurrence (BCR) and clinical recurrence (CLR) after radical prostatectomy (RP), to determine whether the 2014 ISUP grading system is a better predictor of survival compared with the previous Gleason scoring systems, and to investigate whether incorporation of the tertiary pattern/grade into the ISUP scoring system significantly improves its efficacy. PATIENTS AND METHODS: A total of 635 RP cases (1991-1999) were identified from a database at a single institution. A histopathology review was performed to re-grade the cases as per the ISUP 2014 grading system. All relevant clinicopathological data and clinical follow-up (median [range] 15.25 [0.3-26] years) were obtained. Log-rank, Kaplan-Meier, Cox regression and Harrell's concordance c-indices analyses were performed. RESULTS: At a median follow-up of 15 years, 276 patients (44%) had BCR and 41 (7%) had CLR. Grade Groups 1, 2, 3, 4 and 5 were seen in 112 (18%), 307 (48%), 129 (20%), 33 (5%) and 54 patients (9%), respectively: 337 (53%) were upgraded, while 70 (11%) were downgraded compared with the 1992 Gleason system. Grade Group (hazard ratio [HR] 4.9; P < 0.001) and preoperative prostate-specific antigen (PSA) level (HR 1.4; P < 0.001) were independent predictors of BCR. Only Grade Group 5 (HR 12.3; P = 0.02), preoperative PSA (HR 1.6; P < 0.001), stage pT3b (HR 3.1; P = 0.03) and pT4 (HR 12.4; P < 0.001) independently predicted CLR. Harrell's c-indices showed that the 2014 ISUP grading system was a significantly better predictor of BCR and CLR as well as prostate cancer-specific death, compared with the 2005 ISUP modified Gleason system. The replacement of the secondary pattern by the tertiary pattern did not alter the prognostic efficacy of the ISUP 2014 grading system. CONCLUSIONS: The ISUP 2014 grading system is a significant independent predictor of both BCR and CLR, outperforming the 2005 ISUP modified Gleason system. This classification system has the potential to influence clinical decision-making after RP.
引用
- Grogan J, Gupta R, Mahon KL, et al. Predictive value of the 2014 International Society of Urological Pathology grading system for prostate cancer in patients undergoing radical prostatectomy with long-term follow-up. BJU Int. 2017. PMID: 28371244. doi:10.1111/bju.13857
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。